Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies (2015)
- Authors:
- Autor USP: SQUIRE, JEREMY ANDREW - FMRP
- Unidade: FMRP
- Subjects: NEOPLASIAS PROSTÁTICAS (DIAGNÓSTICO); HIBRIDIZAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Abstracts
- Conference titles: Annual Meeting of the American Society of Human Genetics
-
ABNT
SQUIRE, Jeremy Andrew et al. Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. 2015, Anais.. Baltimore: ASHG, 2015. . Acesso em: 12 fev. 2026. -
APA
Squire, J. A., Picanco-Albuquerque, C. G., Morais, C. L., Carvalho, F. L. F., Peskoe, S. B., Hicks, J. L., et al. (2015). Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. In Abstracts. Baltimore: ASHG. -
NLM
Squire JA, Picanco-Albuquerque CG, Morais CL, Carvalho FLF, Peskoe SB, Hicks JL, Ludkovski O, Fedor H, Humphreys E, Han M, Platz EA, Marzo AM de, Berman DM, Lotan DL. Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. Abstracts. 2015 ;[citado 2026 fev. 12 ] -
Vancouver
Squire JA, Picanco-Albuquerque CG, Morais CL, Carvalho FLF, Peskoe SB, Hicks JL, Ludkovski O, Fedor H, Humphreys E, Han M, Platz EA, Marzo AM de, Berman DM, Lotan DL. Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies. Abstracts. 2015 ;[citado 2026 fev. 12 ] - A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer
- Extracellular vesicles: evolving factors in stem cell biology
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- In silico shows that PTEN loss and AR overexpression are associated with increased CD8+ T-cell and Treg density and earlier disease recurrence in prostate cancer
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- STAT1-associated intratumoural TH1 immunity predicts chemotherapy resistance in high-grade serous ovarian cancer
- PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy
- Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
